<DOC>
	<DOCNO>NCT00455208</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Cura-100 treating rheumatoid arthritis osteoarthritis .</brief_summary>
	<brief_title>A Study Evaluating Safety Efficacy Cura-100 Subjects With Rheumatoid Arthritis Osteoarthritis</brief_title>
	<detailed_description>This Phase I/II trial , monitor safety efficacy Cura-100 subject rheumatoid arthritis osteoarthritis one clinical study center . The open-label clinical study use study . The study expect last one half year officially start , include recruitment , study treatment follow-up . The healthy volunteer also include study safety intervention .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Having diagnosis rheumatoid arthritis osteoarthritis active stage Able willing comply study visit procedure specify protocol least six month period Able understand willing sign date write informed consent form prior admission study Able willing provide adequate information locator purpose Able willing provide self evaluation information diagnostic report arthritis require efficacy evaluation Pregnant woman Overweighted Hypertension , diabetes , history cardiovascular disease kidney disease , serious skin allergy concurrent clinically significant illness medical condition ( arthritis ) , viewpoint study doctor , may put subject possible risk participation Patients use biologic modifier therapy currently take immunosuppressive agent might exclude Unable spend 3 hour treatment study center</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>